Page 5 - Biologics Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Biologics inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Biologics Inc Today - Breaking & Trending Today

ADMA Biologics (NASDAQ:ADMA) Posts Quarterly Earnings Results

ADMA Biologics (NASDAQ:ADMA) Posts Quarterly Earnings Results
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

United States , Raymond James , Biologics Inc , Securities Exchange Commission , Cantor Fitzgerald , Get Free Report , Director Steve Elms , Exchange Commission ,

ADMA Biologics (NASDAQ:ADMA) Issues Quarterly Earnings Results, Beats Expectations By $0.03 EPS

ADMA Biologics (NASDAQ:ADMA) Issues Quarterly Earnings Results, Beats Expectations By $0.03 EPS
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

United States , Raymond James , Biologics Company Profile , Securities Exchange Commission , Cantor Fitzgerald , Biologics Inc , Get Free Report , Director Steve Elms , Exchange Commission ,

ADMA Biologics (ADMA) Scheduled to Post Quarterly Earnings on Thursday

ADMA Biologics (ADMA) Scheduled to Post Quarterly Earnings on Thursday
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United States , Biologics Company Profile , Biologics Inc , Cantor Fitzgerald , Securities Exchange Commission , Get Free Report , Director Steve Elms , Exchange Commission ,

Brokerages Set ADMA Biologics, Inc. (NASDAQ:ADMA) Price Target at $7.88

Shares of ADMA Biologics, Inc. (NASDAQ:ADMA – Get Free Report) have earned an average recommendation of “Buy” from the four analysts that are presently covering the firm, Marketbeat reports. Three research analysts have rated the stock with a buy rating and one has issued a strong buy rating on the company. The average 1 year […] ....

United States , American Century Companies Inc , Securities Exchange Commission , Biologics Company Profile , Walleye Capital , Peregrine Capital Management , Cantor Fitzgerald , Biologics Inc , Charles Schwab Investment Management Inc , Rice Hall James Associates , Get Free Report , Director Steve Elms , Exchange Commission , Hall James , Schwab Investment Management , Capital Management , American Century Companies , Century Companies , Get Free , Adma Biologics , Nasdaq Adma ,